PETNet expands biomarker production

Siemens Healthcare subsidiary PETNet Solutions is expanding its imaging biomarker production capabilities in Nottingham, England, to enhance its ability to produce new biomarkers as investigational medicine products (IMPs) in the U.K.

The IMPs include a proprietary hypoxic agent developed by Siemens of Malvern, PA, to identify tumor tissues with low oxygen supply, and a leading investigational amyloid agent for PET imaging of beta-amyloid deposits in the brain.

Related Reading

PETNet builds network, July 7, 2010

Siemens' PETNet offers free F-18 NaF, March 19, 2000

Siemens to supply F-18 NaF via PETNet, March 8, 2010

PETNet to supply ACRIN trial, November 2, 2009

PETNet signs supply deal with Lantheus, June 11, 2009

Copyright © 2010 AuntMinnie.com

Page 1 of 1262
Next Page